chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I?m not sure if this is in my head but I think the vaccine has flared up my reflux.  I received first dose on 12/23/2020 and second dose on  1/10/2021.  Since vaccine I?ve noticed my reflux has been flared.  I haven?t had to take Protonix in months; however, I really started to experience indigestion and chest burning/pressure a week after first dose.  I started back taking Protonix and had to increase dose to twice a day on 1/5/2021.  Symptoms have improved significantly but it?s still somewhat aggravated. I also experienced lower back pain and upper and lower extremities numbness/tingling maybe 2-3 time since first vaccine
Information has been received from a pharmacist concerning a patient of unknown age and gender. No current or historical conditions were reported. On 26-FEB-2015, the patients were vaccinated with an improperly stored dose of ZOSTAVAX (route, dose, Lot# and expiration date not reported). No adverse effects were reported. Additional information has been requested.
fever; redness; welting; Aching; This case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th June 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced fever, erythema of extremities, welts and pain. On an unknown date, the outcome of the fever, erythema of extremities, welts and pain were recovered/resolved.   The reporter considered the fever and pain to be related to Shingrix. It was unknown if the reporter considered the erythema of extremities and welts to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but it was selected as adult as per the vaccine indication. The patient had welting and reaction to elbow. The patient also had hot redness and some welting The patient had aching and low fever expected. Went to pharmacy. Showed her reaction. They tried calling drug company and had not heard. The patient had not received 2nd dose of Shingrix till the time of reporting. The 2nd dose could be given anytime between 2 and 6 months after the 1st dose. The patient asked with the upper arm welting should he get 2nd dose of Shingrix. The events were recovered after one and a half week.
approx 15" p/receiving shots pt brought back to immun room pale, uncomfortable, hyperventilating but alert; vomited vitals BP 110/60, P82, R30; paramedics called to eval; no tx; did not transport
Received Influenza vaccine on 11/17/15. On 11/18/15 he woke up with pain in the left deltoid, at the area of vaccine placement, also he had all motion limited ROM of LUE secondary to pain.
Patient inadvertantly given DTaP and IPV when vaccines had already been administered on 6/27/07. Patient also received MMR #2 at 19 days instead of at 30 days. Patient returned to clinic on same day and showed no signs or symptoms of an adverse reaction; no further treatment if warrented at this time.
mom states feeding pt & lt arm began spasming & jerking involuntarily & rapidly;lasted 10 min;no t,on wed approx 11am episode was repeated;had to hold arm to keep pt from hitting pts head & jerking cont; no episodes since;
Acute renal failure.  Hospitalization for 7 days, hydration, medication change.  Renal function returned to near normal.
woke up in the middle of the night with fever. Took 2 tylenol 500 MG to help me sleep. In the morning I woke up with a headache, nausea body aches and fever. i slept most of the day and could not eat. my stomach felt weak. Took another dose of tylenol to keep the fever down. I felt dizzy some part of the day. today i still have a headache.
Loss of range of motion; Can't sleep; Pain at the injection site; Vaccine was given in the left deltoid bursa instead of the deltoid muscle; A spontaneous report was received from a 65 year-old, female physician, who is also the patient, who received Moderna's COVID-19 vaccine and experienced vaccine was given in the left deltoid bursa instead of the deltoid muscle, loss of range of motion, can't sleep, and pain at the injection site. The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 02 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 011L20A) intramurally in the left deltoid bursa for prophylaxis of COVID-19 infection. On 02 Jan 2021, the patient reported she had been given the vaccine in the wrong location. The vaccine was given in the left deltoid bursa instead of the deltoid muscle. The patient was also experiencing loss of range of motion, pain at the injection site, and she also can't sleep. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was unknown. The event vaccine was given in the left deltoid bursa instead of the deltoid muscle was considered resolved on 02 Jan 2021. The events loss of range of motion, can't sleep, and pain at the injection site were considered not recovered/not resolved.; Reporter's Comments: This report refers to a case of 65 year old female patient who experienced non-serious unexpected events of vaccine was given in the left deltoid bursa instead of the deltoid muscle for mRNA-1273, lot #  011L20A. The patient experienced loss of range of motion, pain at the injection site, and can't sleep. Onset latency was not provided.  De-challenge and re-challenge are not applicable. Based on the information provided the events of vaccine was given in the left deltoid bursa instead of the deltoid muscle, loss of range of motion and can't sleep are assessed as unlikely related to mRNA-1273 as this is due to product administration error. The event of pain at the injection site is included in the known safety profile of the vaccine, hence a causal association cannot be excluded.
Patient received booster for pneumovax from the pcp office on 11/17/2005 and then was admitted to the hospital for surgery, and as part of their protocol, got pneumovax again.  He was discharged post op and returned the next day with fever 103 and painful swollen arm at site of injection extending from deltoid all the way to the forearm. Medical records state rigors. msv
Instantaneous burning and pain during injection. Numbness, tingling and weakness in arm to wrist x 3 days. Itchy welt at injection site size of silver dollar x 5 days. Pain at injection site ongoing.
6cm x 6cm ((R) arm SQ) redness, swelling, hardness, soreness, warmth-instructed to give BENADRYL, apply ice pack, give TYLENOL or MOTRIN.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose12/29/21 2nd dose02/06/21 Diagnosed covid positive:08/27/21 Symptom onset:08/28/21 Exposure:Home Symptoms:cough, fatigue,muscle aches, sorethroat
Heart problems; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (Heart problems) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (Heart problems). At the time of the report, CARDIAC DISORDER (Heart problems) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.       No concomitant information was reported.  Now after the Pfizer patient got worry about a stroke. No treatment information was provided.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 78-year-old female patient received BNT162b2 (BNT162B2), on 21Sep2021 at 09:00 as dose 3 (booster), single (Lot number: FF8839) at the age of 78 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Diverticulosis" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose Number: 2, Batch/Lot No: EL3302, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 23Feb2021, when the patient was 77-year-old, for COVID-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EJ1686, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 02Feb2021, when the patient was 77-year-old, for COVID-19 Immunization. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant) with onset 21Sep2021, outcome "recovered", described as "The morning following day of second shot and again morning following the day of third shot, I passed out. This happened 12 plus hours after the shot, so was not a reaction from fear of the shot". Therapeutic measures were not taken as a result of loss of consciousness. Clinical course: The patient did not received any other vaccine within four weeks. The patient not had COVID Prior vaccination and not tested COVID post vaccination. Follow-up attempts are completed. No further information is expected. Sender's Comments: Linked Report(s): US-PFIZER INC-202201157480 same reporter/patient/AE, different drug dose.
Lost sense of taste / Still cant taste; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost sense of taste / Still cant taste) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 018B21A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN for Cholesterol, CALCIUM and VITAMIN D NOS for Supplementation therapy, LEVOTHYROXINE for Thyroid stimulating hormone deficiency.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced AGEUSIA (Lost sense of taste / Still cant taste). At the time of the report, AGEUSIA (Lost sense of taste / Still cant taste) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information mentioned.  Action taken with respect to mRNA-1273 was not applicable.  Patient reported that even after second dose of the vaccine, still cant taste.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Additional information added on 16JUN2021 contains significant information which includes contact information, height, weight, race and new event.
POTS; Dysautonomia; syncope; constipation; Arm/Shoulder/Joint pain; Sinus tachycardia; Information has been received from a consumer via the Administration (# 857405) on 17-AUG-2022, regarding a 14-year-old non-pregnant female patient (also reported as male, inconsistent information). The patient's concurrent conditions included asthma. Previous drug reactions, or allergies reported were bee venom (also reported as honey bee, inconsistent information) and strawberries.  On 03-FEB-2018 at 15:00 (also reported as 15:36, inconsistent information), the patient was vaccinated with hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) intramuscular (strength, dose, frequency, anatomical location, indication, lot number, and expiration date were not provided) indicated as prophylaxis. On the same fay, the patient was vaccinated with 1 dose of hepatitis A vaccine, inactivated (VAQTA)(also reported as hep a (HAVRIX), inconsistent information) intramuscular in the right arm (lot number N014945 has been verified to be a valid lot number, expiry date 17-JUN-2019) also indicated as prophylaxis.   On 06-MAR-2019 (also reported as 06-APR-2019, inconsistent information), the patient experienced POTS (postural orthostatic tachycardia syndrome), dysautonomia (autonomic nervous system imbalance), syncope, constipation, arm/shoulder/joint pain (arthralgia), and sinus tachycardia (hospitalization and disability criteria for ). Additional laboratory and diagnostical tests were performed: electrocardiogram (EKG), electroencephalogram (EEG), Holter Monitor 1 week; "Holter monitor" 30 days; medtronic LOOP monitor implant in chest wall; full laboratory panels, thyroid panels, genetics review and counseling to rule out potential for anything else that could have contributed.  The outcome of the aforementioned events was reported as not recovered.  The causality assessment was not provided.  Follow-up information has been received via telephone call to the physician office on 01-SEP-202 An unspecified reporter, stated that they could not help without a name and date of birth of the patient. The reporter was unable to find a healthcare provider who was completed the adverse event report. Additional information was not expected, all scheduled correspondence was canceled.
dizziness; throat dryness; nausea; This is a spontaneous report from a non-contactable healthcare professional . A 23-year-old male patient received bnt162b2 (BNT162B2, lot number:EH9899), intramuscularly in his left arm  on 22Dec2020 11:00 at a single dose for covid-19 immunization (reported as covid-19 vaccination). The patient's medical history included GI symptoms that he was currently being worked up for. Patient reported onset of similar signs around time of vaccine injection. The patient's concomitant medications were not reported. During his 15 minute waiting period after the injection, the patient began to experience dizziness, throat dryness, and nausea. He denied rash, hives, difficulty breathing, difficulty swallowing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling. The provider was notified of patient reaction and he was then assessed in the emergency bay area. Monitored patient for severe reaction symptoms, including rapid progression of symptoms, respiratory distress with stridor, vomiting, abdominal pain and hypotension. Outcome of the events was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained.
Really tired; Little stomach ache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (Lot number: EN6208) as dose number unknown, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "Really tired"; ABDOMINAL PAIN UPPER (non-serious), outcome "unknown", described as "Little stomach ache".  No follow-up attempts are possible. No further information is expected.
Information has been received from research (manuf control #HQWYE740318APR03) concerning a 13 month old male who on 10/9/02 was vaccinated with a dose of varicella virus vaccine live. On 10/18/02 the pt developed viral syndrome and febrile seizures. Upon internal review, it has been determined that viral syndrome and febrile seizures were considered to be other important medical events (OMIC). Additional info has been requested.  A 15-day follow up report received 7/3/2003 adds: Follow up info from a health professional indicated that the pt is enrolled in a Wyeth IND study (study title not provided). Therefore, this is not a spontaneous report and only limited info is available. Additionally, the investigator felt that the adverse events were related to the vaccination with varicella virus vaccine live and measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (MSD). Upon internal review, it has been determined that viral syndrome and febrile seizures were considered to be other important medical events. The case is closed.
Patient Began experiencing shakiness, tremor, feeling of ?rush? approximately 15 minutes after the vaccination. He was immediately assessed by EMS crew. Blood pressure 156/72 initially. Pulse is 64, respirations 20. He said he had a tight feeling in the neck and felt flushed. Oxygen saturation was 99%. Patient was given 25 mg oral Benadryl after five minutes of symptoms. He continued to be monitored. His symptoms improved mildly, But he continued to complain of a rush like sensation. It was recommended that the patient be transported to the hospital for at least six hours of monitoring. The patient declined and signed an AMA form. Patient monitored for a total of 45 minutes before allowed to be escorted out of the building with his wife, with instructions to present to the ER mediately if any symptoms worsen or did not improve within the next five hours.
Body aches; Swelling; pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), SWELLING (Swelling) and PAIN (pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029V20A or 029K20A and 025J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced SWELLING (Swelling) and PAIN (pain). On 04-Feb-2021, the patient experienced PAIN (Body aches). At the time of the report, PAIN (Body aches), SWELLING (Swelling) and PAIN (pain) outcome was unknown.            Treatment included antibiotics and anti-inflammatory after 1st dose . Benadryl and ibuprofen after 2nd dose.
lymph nodes have not gone down, the glands in his neck have been swollen since April; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset Apr2021, outcome "not recovered", described as "lymph nodes have not gone down, the glands in his neck have been swollen since April". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Statement attached (enclosed). On July 6th 2012, I received a shingles vaccine because  I once had chicken pox as a child. By the second day after I had received the vaccine, I noticed a small area of shingles which appeared for the first time ever in my life and it is located on my left side area between the breast and arm pit. They are bright red and appear like blister size welts, which I still have as I write this letter. In addition to the shingles I also developed a small case of chicken pox to go with it and I believe a low grade temp is normal. Why didn't I take the Blue pill instead of the Red Pill? (A quote from a movie). I hope the FDA wasn't out to lunch on this one while the scientist who made this vaccine cash in as they say......get it out..... and.....sell, sell, sell. I believe this product came out to fast and should of had more research, before profiting off the public and stock. More than 55 years since chickenpox and healthy every day since then and Today I now have shingles and chicken pox. I was doing well until I received the vaccine.
both hands swollen felt on fire-trouble sleeping;both ankles extremely sore;lt shoulder joint very sore;
TEMPERATURE EXCURSION DOSES ADMINISTERED TO PATIENTS; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned multiple patients. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced temperature excursion doses administered to subjects, and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the temperature excursion doses administered to patients and incorrect product storage was not reported. This report was non-serious.
Information has been received via the Merck pregnancy registry, from a registered nurse, concerning a 15 year old female patient, who on 03-MAR-2008 was vaccinated with a dose of GARDASIL (lot # not reported). During the appointment, the patient mentioned that her period began on 02-MAR-2008. However, after the physical exam, the physician ordered a pregnancy test, and the results were positive (date of LMP and gestation details were not provided). On 03-MAR-2008, a physical exam and urine pregnancy test were positive. No symptoms have been reported. Information has been received from a physician concerning a 14 year old female with eczema, asthma, left clubfoot and refractive error with a history of 0 pregnancies and 0 live births and a history of bacterial infection due to streptococcus, group b and positive for Chlamydia trachomatis and gonococcus, who on 03-MAR-2008 was vaccinated with first dose of GARDASIL (dose, route not reported, lot number 659657/1487U). Concomitant therapy included FLOVENT and albuterol.  The physician reported that on 05-JUN-08, the patient delivered a normal, healthy female baby weighing 7 pounds 8 ounces. A hearing test was performed on 05-JUN-2008 and 06-JUN-2008 and failed for right ear both times. Apgar score was 8/9. Hearing test was performed again on 24-FEB-2009 and the patient passed the test for both ears. No further information is available.
Flumist given on Thursday, Sept. 17, 2009.  Symptoms started Saturday with sore throat and a little drainage.  By Monday, Sept. 21, low grade fever.  By Tuesday, Sept. 22, fever of 102 degrees.
patient experienced  numbness, and tingling in both hands. Stated that is was similar to carpel tunnel syndrome
Blurry vision, fall from exam table hitting the floor on his face, jerking of legs for <10 sec., ~ 10 sec. Loss of consciousness per mother, faintness and weakness despite being laid down first on the floor, then carefully helped on to the exam table, nauseated, given water, HR- 80/min., pallor, was alert and oriented, complained of headache in the back of his head, PERL. Observed closely, since continued weak and slightly pale, begun Oxygen via mask and called Paramedics. Observed to be alert and with normal BP and hence helped to the car; Non-contrast head CT done around 3:30 PM, which was Negative. Sent home with parents and followed closely via telephone.